Teva Pharmaceutical is acquiring Cephalon Inc. for $81.50 per share, or $6.8B in cash

Cephalon Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Teva Pharmaceutical Industries Ltd.

Israel / Mid-Cap Biopharma ($1-$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed